NCT05966753
Completed
Not Applicable
Observational Study on the Management, and Progression of Patients With Diabetic Macula Edema (DME)
ConditionsDiabetic Macular Edema
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetic Macular Edema
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 221004
- Locations
- 1
- Primary Endpoint
- Change in visual acuity
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
This study aims to characterize patients with diabetic macular edema (DME), their progression, the treatment received and associate the functional and physiological outcomes related to the treatment.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients ≥18 years, with a DME diagnosis in at least one eye, included in the Vestrum database identified during the study period (January 2015 to April 2023)
Exclusion Criteria
- •Patients without the information of laterality will be excluded.
Outcomes
Primary Outcomes
Change in visual acuity
Time Frame: From January 2015 to April 2023
Progression to DME in the fellow eye
Time Frame: From January 2015 to April 2023
Central retinal thickness (CRT)
Time Frame: From January 2015 to April 2023
Initial treatment of DME
Time Frame: From January 2015 to April 2023
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic OutcomeDiabetic Macular EdemaNCT05080803European School of Advanced Studies in Ophthalmology608
Unknown
Not Applicable
Reading Center - Occurence of Diabetic Macular Edema in Patients With Diabetes Mellitus in Slovak RepublicDiabetic Macular EdemaDiabetic RetinopathyNCT02063321Emil Martinka762
Unknown
Not Applicable
Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.Macular EdemaNCT04601675He Eye Hospital100
Completed
Phase 4
A Study to Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular DegenerationDiabetic Macular EdemaNeovascular Age-related Macular DegenerationNCT06591598Bayer51
Completed
Not Applicable
Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES)Diabetic Macular EdemaNCT01947881Association for Innovation and Biomedical Research on Light and Image71